| The Food and Drug Administration acted after a pivotal trial showed that the medication, Leqembi, modestly slowed progression of the illness. But skeptics note that the drug, which is administered intravenously every other week, can cause side effects such as brain bleeding and swelling. | 
No comments:
Post a Comment